RxDoctor Payments Data

Edward Nelson, MD

Hematology & Oncology · Orange, CANPI 1780764951

Payments from drug & device makers

$141,962in general payments, 2019–2025

Across 8 payments — averaging $17,745 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$104K
  • Genentech, Inc.$22K
  • TG Therapeutics, Inc.$16K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astrazeneca UK Limited3$104,300
Genentech, Inc.1$21,762
TG Therapeutics, Inc.4$15,900

How this compares

$141,962 in reported general payments places this provider in the 75th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California

Medicare billing

Part B allowed, 2024
$15,426
Medicare patients
71
Services billed
135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ImbruvicaIbrutinib34$685,935
CalquenceAcalabrutinib Maleate12$178,374
Gamunex-CImmune Globul G/Gly/Iga Avg 4616$26,306
Potassium Chloride15$178
Allopurinol11$62

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →